Acquisitions (Tables)

6 Months Ended

Jun. 30, 2019

Schedule of proforma results

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Revenue	$	76,255	$	60,715	$	142,961	$	118,301
Net loss		(6,395)		(35,803)		(18,104)		(59,889)
Net loss per share, basic and diluted		(0.31)		(1.86)		(0.88)		(3.13)

Prescribe Wellness

Schedule of allocation of the purchase price based on the estimated fair values of the assets acquired and liabilities

Accounts receivable	$	2,608
Prepaid expenses and other current assets		1,345
Property and equipment		1,155
Operating lease right-of-use-assets		1,467
Trade name		4,100
Developed technology		20,000
Patient database		21,700
Client relationships		74,100
Goodwill		30,846
Total assets acquired	$	157,321
Operating lease liabilities		(1,467)
Trade accounts payable		(1,733)
Accrued expenses and other liabilities		(5,495)
Total purchase price	$	148,626

DoseMe

Schedule of purchase price consideration

Cash consideration at closing, net of post-closing adjustments	$	10,136
Stock consideration at closing		9,504
Estimated fair value of contingent consideration		8,720
Total fair value of acquisition consideration	$	28,360

Schedule of allocation of the purchase price based on the estimated fair values of the assets acquired and liabilities

Accounts receivable	$	9
Prepaid expenses and other current assets		110
Trade name		89
Developed technology		16,200
Non-competition agreements		500
Goodwill		11,831
Total assets acquired	$	28,739
Trade accounts payable		(17)
Accrued expenses and other liabilities		(362)
Total purchase price, including contingent consideration of $8,720	$	28,360